Medications Prescribed for Osteoporosis
Medications Prescribed for Osteoporosis
Osteoporosis results when there are low levels of minerals such as
calcium and phosphorous in the bones. Bones that are porous may lead
to osteoporosis, and possibly eventual fractures. Factors that may increase
the risk of developing osteoporosis include older age, small body
frame, and lack of physical activity. Certain medications may also increase
the risk of developing osteoporosis, such as corticosteroids (Prednisone)
if used for an extended period of time. Symptoms of this condition
include back pain, stooped posture, and fractures of the wrists,
hips, or other bones. Bone density is critical in determining the development
of osteoporosis. Persons with lower bone density are more likely to
develop osteoporosis later in life.
Bisphosphonates work to maintain bone mass, prevent the breakdown
of bone, and increase bone density. Alendronate (Fosamax) is a
bisphosphonate that may be taken daily or weekly. Zoledronic acid
(Reclast), another bisphosphonate, was approved recently as a once
yearly intravenous infusion for osteoporosis. Raloxifene (Evista) is a
selective estrogen receptor modulator (SERM). This medication provides
similar beneficial effects on bone tissue as does estrogen; however it
does not have some of the same risks as does estrogen.